Fresenius Medical Care AG (FMS)
FMS trades on NYSE in Health Care, Misc Health and Biotechnology Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC filing XBRL, 20-F (ifrs-full:Revenue), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1333141/000110465926019005/0001104659-26-019005-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), fiscal year ended 2025-12-31. Converted from EUR at 0.9048 per USD (today's ECB or Federal Reserve reference rate).
Profile
| Field | Value |
|---|---|
| Ticker | FMS on NYSE |
| Sector | Health Care |
| Industry | Misc Health and Biotechnology Services |
| Country | Germany |
| IPO year | Not reported by the screener |
| SEC CIK | 0001333141 |
| SEC industry code | Services-Misc Health & Allied Services, NEC |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $21.7B |
| Net income | $1.1B |
| Operating income | $2.0B |
| Net margin | 5.0% |
| Operating margin | 9.3% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $1.8B |
| Total assets | $34.3B |
| P/E (computed) | 11.3× |
| P/S (computed) | 0.6× |
Reported in EUR; shown in US dollars.
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 20-F 2026-02-24 |
| Cash and burn | $1.8B cash; operating cash flow $740.8M a quarter. | Report 2025-12-31 |
| Shares outstanding | No cover-page share count in XBRL | Cover page 2025-12-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft, Frankfurt, Germany | PCAOB Form AP 2026-03-12 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | $21.7B | $1.1B | $3.0B | $1.8B | $11.9B | $21.7B | 20-F 2026-02-24 |
| FY 2016 2016-12-31 | Not filed | $1.2B | $2.1B | $747.2M | $8.6B | Needs four quarters | 20-F 2017-02-22 |
| FY 2015 2015-12-31 | Not filed | $1.0B | $2.0B | $549.5M | $8.6B | Needs four quarters | 20-F 2017-02-22 |
| FY 2014 2014-12-31 | $5.3B | $1.0B | $1.9B | $633.9M | $9.5B | $5.3B | 20-F 2015-02-25 |
| FY 2013 2013-12-31 | $5.0B | $1.1B | $2.0B | $682.8M | $8.4B | $5.0B | 20-F 2014-02-25 |
| FY 2012 2012-12-31 | Not filed | $1.2B | $2.0B | $688.0M | $8.2B | Needs four quarters | 20-F 2015-02-25 |
| FY 2011 2011-12-31 | Not filed | $1.1B | $1.4B | $457.3M | $7.2B | Needs four quarters | 20-F 2014-02-25 |
| FY 2010 2010-12-31 | Not filed | $978.5M | $1.4B | $522.9M | $4.7B | Needs four quarters | 20-F 2013-02-26 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2023-06-06 |
| Latest annual report FORM 20-F | 20-F | 2026-02-24 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-11-09 |
Source: SEC EDGAR submissions feed, 602 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -5.9% |
| 1 month | +4.5% |
| 3 months | -6.8% |
| Year to date | -7.5% |
| 1 year | -7.0% |
| From 52-week high | -14.3% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Misc Health and Biotechnology Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| DVA | DaVita Inc. | $174.22 | -0.19% | $11.0B |
| SHC | Sotera Health Company | $16.25 | -2.17% | $4.6B |
| PGNY | Progyny Inc. | $37.15 | +2.68% | $2.7B |
| AGL | agilon health inc. | $116.75 | +0.94% | $2.0B |
| VMD | Viemed Healthcare Inc. Common Shares | $9.15 | -0.22% | $346.7M |
| PARK | Park Dental Partners Inc. | $19.72 | -8.24% | $109.2M |
| CCEL | Cryo-Cell International Inc. | $4.55 | -6.19% | $36.7M |
| MGRX | Mangoceuticals Inc. | $0.1603 | +3.42% | $3.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier